The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Catenae Innovation Plc: Directorate change

18 Jul 2019 12:18



Catenae Innovation Plc: Directorate change

CATENAE INNOVATION PLC("Catenae" or the "Company")

Directorate Changes

Catenae (AIM: CTEA), the AIM quoted provider of digital media and technology, announces the resignation of Tony Sanders as a director of the Company and the appointment of Mr Anthony Flynn as a Non-Executive Director with immediate effect.

Resignation of Tony Sanders

Tony, who became Interim CEO in September 2017 and CEO in June 2018, has guided the Company through significant changes and developments, including the Company’s move into Blockchain technology.

Due to changes in personal circumstances, Tony feels he is unable to commit to continue as CEO and Chair of the Board. Nevertheless, he will maintain some ongoing involvement with the day to day business going forward, assisting in the promotion of the OnSuite product set and Blockchain products.

The Board would like to thank Tony for all his efforts and look forward to his continued support of the business.

Board Changes

Guy Meyer, Business Development Director, will take on the role of Interim CEO to lead the business through the next strategic phase of its development. The board also announces that Mr Kevin Everett takes on the role of Interim Non-Executive Chairman with immediate effect. Kevin first joined the Board as a Non-Executive Director on 16 May 2013.

Appointment of Anthony Flynn

The board is pleased to announce that Mr Anthony Michael Flynn has been appointed as Non-Executive Director with immediate effect.

The appointment of Anthony Flynn significantly strengthens the capabilities of the board, as well as contributes to its enhanced corporate governance. Mr. Flynn worked at de Zoete & Bevan in their Brokerage division, then in 1986 became a Director of Equities at BZW in London and finally in 1998 as Founder & CEO he set up XBZ Ltd. - a successful boutique Derivatives and Brokerage firm.

XBZ specialised in providing advice, price discovery and the execution of pan European Equity Derivatives to Financial Institutional clients, Inter Dealer Brokers (IDB), large proprietary Traders and Hedge Funds. The firm was recognised as one of the major sources of volume in each derivative exchange.

Mr. Flynn completed the final disposal of his holdings in XBZ in 2015. In the intermediary years he has provided consultancy services to SMEs in various capacities covering structural, financial and corporate governance.

The following information is disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies:

Anthony Michael Flynn, aged 59, does not hold any directorships nor partnerships and has not done so in the past 5 years.

Anthony Michael Flynn is beneficially interested in 31,079,661 ordinary shares, representing 0.95% of the Company’s issued ordinary share capital. Anthony Michael Flynn does not hold any options nor warrants of the Company’s ordinary shares.

There is no further information to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Kevin Everett, Interim Non-Executive Chairman

For further information:

Catenae Innovation PlcGuy MeyerTel: 020 7929 7826
Cairn Financial Advisers LLP, Nominated AdviserLiam Murray / Jo Turner Tel: 020 7213 0880
Turner Pope Investments (TPI) Limited, BrokerAndrew Thacker Tel: 020 3621 4120


Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.